{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:44:33Z","timestamp":1781844273845,"version":"3.54.5"},"reference-count":24,"publisher":"Bentham Science Publishers Ltd.","issue":"1","license":[{"start":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:00:00Z","timestamp":1695340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/legalcode"}],"funder":[{"DOI":"10.13039\/501100004607","name":"General Program of Guangxi Natural Science Foundation","doi-asserted-by":"publisher","award":["2022JJA140788"],"award-info":[{"award-number":["2022JJA140788"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Open project of Guangxi Zhuang Yao medicine Key Laboratory","award":["GXZYZZ2020A-14"],"award-info":[{"award-number":["GXZYZZ2020A-14"]}]},{"DOI":"10.13039\/501100011833","name":"key project of Guangxi University of Chinese Medicine","doi-asserted-by":"publisher","award":["2017ZD002"],"award-info":[{"award-number":["2017ZD002"]}],"id":[{"id":"10.13039\/501100011833","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CAD"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Caulis Spatholobiis one of the necessary Chinese herbal medicines for\nhematologists in the treatment of malignant tumors, but its potential targets and molecular mechanisms\nneed further exploration.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>This study aimed to predict the relevant targets of the treatment of chronic myeloid leukemia\n(CML) with Caulis Spatholobi by applying the network pharmacology method, and in vitro cell\nexperiments were conducted to verify the mechanism of Caulis Spatholobi in the treatment of CML.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>TCMSP, ETCM, Genecards, and GisGeNET databases were used to obtain relevant\ntargets of Caulis Spatholobi in the treatment of CML. Go and KEGG analyses were performed\nusing the David database. Using Cytoscape 3.7.2, the \"active compounds-targets-pathways\" network\nwas constructed. Further validation was carried out by pharmacological experiments in vitro.\nThe proliferation and apoptosis of K562 cells were observed by the MTT method and Hoechst\n33242 fluorescence staining method. The predicted targets and their related signal pathways were\nverified by western blotting.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>In this study, 18 active compounds and 43 potential targets were obtained. The results of\nthe MTT method showed that compared with the normal control group, 62.5-500 \u03bcg\/mL alcohol\nextract of Caulis Spatholobi had an obvious inhibitory effect on K562 and the IC50 value was less\nthan 100 \u03bcg\/mL. The Hoechst 33242 fluorescence staining method showed that the alcohol extract\nof Caulis Spatholobi could promote apoptosis. The results of western blotting showed that compared\nwith the normal control group, the expressions of Bax and Caspase-3 proteins in the 62.5 and\n125 \u03bcg\/mL alcohol extract of Caulis Spatholobi groups were significantly up-regulated (p &lt; 0.05).\nThe expression of Bcl-2 in the 125 \u03bcg\/mL alcohol extract of the Caulis Spatholobi group was significantly\ndown-regulated (p &lt; 0.01), and the expression of Bcl-2 in the 62.5 and 31.25 \u03bcg\/mL alcohol\nextract of Caulis Spatholobi groups was also significantly down-regulated (p &lt; 0.05). It showed that\nthe ethanol extract of Caulis Spatholobus could promote apoptosis by up-regulating the expression of\nBax and caspase-3 and down-regulating the expression of the Bcl-2 protein.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The treatment of Caulis Spatholobi for CML has the characteristics of multi-targets\nand multi-pathways. The results of in vitro pharmacological experiments demonstrated that its\nmechanism of action might be based on the expression of key target proteins, such as Caspase-3,\nBcl-2, and Bax, thereby inhibiting cell proliferation and promoting cell apoptosis, which provides\na scientific basis for the treatment of CML.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573409919666230417085106","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T09:12:56Z","timestamp":1681722776000},"page":"49-59","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Molecular Mechanism of Caulis Spatholobi in the Treatment of Chronic\nMyeloid Leukemia based on Network Pharmacology and Experimental\nVerification"],"prefix":"10.2174","volume":"20","author":[{"given":"Yanchun","family":"Wu","sequence":"first","affiliation":[{"name":"School of Pharmacy, Guangxi University of Chinese Medicine, Guangxi, 530200, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Lian","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital\nof Guangxi Medical University, Guangxi, 530021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Guangxi University of Chinese Medicine, Guangxi, 530200, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Guangxi University of Chinese Medicine, Guangxi, 530200, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linli","family":"Wei","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Guangxi University of Chinese Medicine, Guangxi, 530200, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Tian","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Guangxi University of Chinese Medicine, Guangxi, 530200, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"2485","volume":"38","author":"Yang W.H.","year":"2011","unstructured":"Yang W.H.; Wang X.L.; Shi Z.X.; Clinical and experimental development of traditional Chinese medicine for the treatment of chronic myeloid leukemia. Liaoning J Tradit Chinese Med 2011,38(12),2485-2486","journal-title":"Liaoning J Tradit Chinese Med"},{"key":"ref=2","first-page":"24","author":"Liu Y.L.","year":"2014","unstructured":"Liu Y.L.; On the research status and progress of leukemia. Contemporary Medical Symposium 2014,24-25","journal-title":"Contemporary Medical Symposium"},{"key":"ref=3","first-page":"797","volume":"29","author":"Chen W.F.","year":"2021","unstructured":"Chen W.F.; Yu C.H.; Hu Y.; Analysis of the disease burden of leukemia in China 1990-2017. Chronic Disease Prevent. Control China 2021,29(10),797-800","journal-title":"Control China"},{"key":"ref=4","first-page":"860","volume":"34","author":"Shi J.J.","year":"2021","unstructured":"Shi J.J.; Wang Y.; Su Y.Q.; Relationship between expression levels of serum COX-2,bFGF,TGF\u03b21 and VEGF and disease severity in patients with chronic myeloid leukemia. J Clin Hematol 2021,34(12),860-863","journal-title":"J Clin Hematol"},{"key":"ref=5","first-page":"31","author":"Wang Z.X.","year":"1998","unstructured":"Wang Z.X.; Zhou A.X.; Yang L.; Report of 6 cases of chronic myeloid leukemia surviving for more than 10 years treated with Qinghuang powder. J Leuk Lymphoma 1998(02),31-32","journal-title":"J Leuk Lymphoma"},{"key":"ref=6","author":"Pang A.M.","year":"2001","unstructured":"Pang A.M.; Clinical observation and experimental study on the effects of Manbailing capsules on sIL-2RIL-2 OF serum in chronic myeloid leukemia patients; Heilongjiang University of Traditional Chinese Medicine 2001"},{"key":"ref=7","first-page":"1","author":"Wang L.L.","year":"2002","unstructured":"Wang L.L.; Professor ammin Chen experience in treating leukemia. Sichuan Zhong Yi Xue 2002(09),1-2","journal-title":"Sichuan Zhong Yi Xue"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.3892\/or.2016.5184","volume":"36","author":"Chen X.","year":"2016","unstructured":"Chen X.; Li Q.; Kan X.X.; Wang Y.J.; Li Y.J.; Yang Q.; Xiao H.B.; Chen Y.; Weng X.G.; Cai W.Y.; Zhu X.X.; Extract of Caulis Spatholobi, a novel blocker targeting tumor cell-induced platelet aggregation, inhibits breast cancer metastasis. Oncol Rep 2016,36(6),3215-3224","journal-title":"Oncol Rep"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/ptr.1226","volume":"17","author":"Kang I.C.","year":"2003","unstructured":"Kang I.C.; Kim S.A.; Song G.Y.; Baek N.I.; Park Y.D.; Ryu S.Y.; Saiki I.; Kim S.H.; Effects of the ethyl acetate fraction of Spatholobi caulis on tumour cell aggregation and migration. Phytother Res 2003,17(2),163-167","journal-title":"Phytother Res"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1248\/bpb.27.1348","volume":"27","author":"Ha E.S.","year":"2004","unstructured":"Ha E.S.; Lee E.O.; Yoon T.J.; Kim J.H.; Park J.O.; Lim N.C.; Jung S.K.; Yoon B.S.; Kim S.H.; Methylene chloride fraction of Spatholobi Caulis induces apoptosis via caspase dependent pathway in U937 cells. Biol Pharm Bull 2004,27(9),1348-1352","journal-title":"Biol Pharm Bull"},{"key":"ref=11","first-page":"49","author":"Liang N.","year":"2008","unstructured":"Liang N.; Wei S.J.; Pang Y.Z.; Study Effects of Serum Con taining Suberect Spatholobus in L1210 Cells. J Med Pharm Chin 2008(07),49-52","journal-title":"J Med Pharm Chin"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S1875-5364(13)60037-0","volume":"11","author":"Li S.","year":"2013","unstructured":"Li S.; Zhang B.; Traditional Chinese medicine network pharmacology: Theory, methodology and application. Chin J Nat Med 2013,11(2),110-120","journal-title":"Chin J Nat Med"},{"key":"ref=13","first-page":"64","volume":"24","author":"Gao Z.J.","year":"2022","unstructured":"Gao Z.J.; Zhu T.T.; Niu X.R.; Research progress of chemical constituents and pharmacological activities of Jixueteng (Spatholob Caulis). Liaoning Zhongyiyao Daxue Xuebao 2022,24(04),64-67","journal-title":"Liaoning Zhongyiyao Daxue Xuebao"},{"key":"ref=14","first-page":"70","volume":"13","author":"Huang Y.Y.","year":"2022","unstructured":"Huang Y.Y.; Lai Z.Q.; Cai Y.F.; Research Progress on chemical constituents and pharmacological effects of Caulis Spatholobi. Chinese Manipulat Rehabilitat Med 2022,13(5),70-74","journal-title":"Chinese Manipulat Rehabilitat Med"},{"key":"ref=15","first-page":"1","author":"Chen G.T.","year":"2022","unstructured":"Chen G.T.; Cui Y.L.; Mechanism of YiqiTongmai formula against lschemic stroke: Based on network pharmacology and experimental validation. Pharmacol Clinics Chinese Mater Medic 2022,1-24","journal-title":"Pharmacol Clinics Chinese Mater Medic"},{"key":"ref=16","first-page":"1655","volume":"24","author":"Liang Y.S.","year":"2013","unstructured":"Liang Y.S.; An R.; Liu J.M.; Determination of genistein and formononetin in Caulis Spatholobi from different habitats. Lishizhen Medic Mater Medic Res 2013,24(07),1655-1657","journal-title":"Lishizhen Medic Mater Medic Res"},{"key":"ref=17","first-page":"5","volume":"20","author":"Lin M.","year":"1989","unstructured":"Lin M.; Li S.Z.; Studies on the chemical constituents of Spatholobus micranthoides. Chin Tradit Herbal Drugs 1989,20(02),5-8","journal-title":"Chin Tradit Herbal Drugs"},{"key":"ref=18","first-page":"29","volume":"20","author":"Zhang H.Y.","year":"2011","unstructured":"Zhang H.Y.; Studies on the chemical constituents of Caulis Spatholobi. Chinese J Ethnomed Ethnopharm 2011,20(03),29-33","journal-title":"Chinese J Ethnomed Ethnopharm"},{"key":"ref=19","first-page":"301","volume":"22","author":"Zhai L.","year":"2014","unstructured":"Zhai L.; Li X.X.; Chen Y.; Phenolic Constituents from the Stems of Spatholobus suberectus Dunn. Redai Yaredai Zhiwu Xuebao 2014,22(03),301-306","journal-title":"Redai Yaredai Zhiwu Xuebao"},{"key":"ref=20","first-page":"362","volume":"20","author":"Tu C.","year":"1999","unstructured":"Tu C.; Zhang G.; Lu H.; Study of apoptosis induced by indomethacin in chronic myeloid leukemia. Zhonghua Xue Ye Xue Za Zhi 1999,20(7),362-365","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11011-019-00508-y","volume":"35","author":"Nasehi M.","year":"2019","unstructured":"Nasehi M.; Torabinejad S.; Hashemi M.; Vaseghi S.; Zarrinelast M.R.; Effect of cholestasis and Neuro Aid treatment on the expression of Bax,Bcl-2,Pgc-1 \u03b1 and T fam genes involved in apoptosis and mitochondrial biogenesis in the striatum of male rats. Metab Brain Dis 2019,35(1),183-192","journal-title":"Metab Brain Dis"},{"key":"ref=22","author":"Guo X.M.","year":"2016","unstructured":"Guo X.M.;  The effect of Edaravone on apoptosis in the acute lung injury rats lung cellular 2016","journal-title":"The effect of Edaravone on apoptosis in the acute lung injury rats lung cellular"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1080\/07357900802438585","volume":"27","author":"Odonkor C.A.","year":"2009","unstructured":"Odonkor C.A.; Achilefu S.; Modulation of effector caspase cleavage determines response of breast and lung tumor cell lines to chemotherapy. Cancer Invest 2009,27(4),417-429","journal-title":"Cancer Invest"},{"key":"ref=24","first-page":"2232","volume":"51","author":"Meng F.C.","year":"2020","unstructured":"Meng F.C.; Tang L.D.; Challenges and prospect in research of Chinese materia medica network pharmacology. Chin Tradit Herbal Drugs 2020,51(08),2232-2237","journal-title":"Chin Tradit Herbal Drugs"}],"container-title":["Current Computer-Aided Drug Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573409919666230417085106","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/215866\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573409919666230417085106","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T12:21:37Z","timestamp":1698150097000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/215866\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573409919666230417085106","relation":{},"ISSN":["1573-4099"],"issn-type":[{"value":"1573-4099","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-07-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-27","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}